Healthcare, Regulatory and Reimbursement Landscape Russia

GlobalData, June 2012, Pages: 178

Healthcare, Regulatory and Reimbursement Landscape - Russia

Summary

GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Russia”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

Russia's population decreased at a CAGR of 0.1% between 2005 and 2010. As in most developed countries, the population contains a high proportion of elderly people, with approximately 13.2% of the population above the age of 65 years in 2010. The disease burden associated with this large elderly population is expected to boost growth in the pharmaceutical market, although hinder growth in the economy at the same time. Russia's pharmaceutical market is one of the fastest growing markets in the world, and was valued at approximately $18.7 billion in 2010, having grown at a CAGR of 23% from 2005. The medical device market is one of the most stable industries in the healthcare sector. The main segments in 2010 were diagnostic imaging, ophthalmic devices, cardiovascular devices, in vitro diagnostics and diabetes care devices.

The positive trends in the healthcare market can be attributed primarily to -
- Large elderly population
- Increased government spending
- Government initiatives focusing on the prevention and management of chronic diseases
- Government efforts to simplify regulatory guidelines
- Increased prevalence of non-communicable diseases

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape, and its scope includes -
- Overview of the pharmaceutical and medical devices markets, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analysis of the major players in the pharmaceutical and medical device markets.
- Insightful review of the reimbursement and regulatory landscape, including details of the reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices.
- A detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to buy

The report comprehensively covers both the pharmaceutical and the medical device markets. It will enhance your decision-making capability and allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market in Russia.
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, and pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the main competitors.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships.
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of the Pharmaceutical and Medical Device Market
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Supply Channels
3.1.3 Market Segments
3.1.4 Major Therapeutic Areas
3.1.5 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Drug Price Trends
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 New Drug Approval Process
4.2.3 New Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 Government Structural Balance
5.3.9 Government Gross Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Share of Public and Private Sectors
5.6.4 Spending on Pharmaceutical R&D
5.7 Trade Associations
5.7.1 Association of Russian Pharmaceutical Manufacturers
5.7.2 Association of International Pharmaceutical Manufacturers
5.7.3 Russian Association of Pharmaceutical Marketing
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panel Validation
7.4 Contact Us
7.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceutical Market ($bn), Russia, 2005–2010
Table 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011–2020
Table 3: Sources of Pharmaceuticals, Russia, Share (%), 2008–2010
Table 4: Innovative and Generic Products, Russia, Market Share (%), 2007
Table 5: Wholesaler Mark-ups (%), Various Countries, 2008
Table 6: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005–2010
Table 7: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009
Table 8: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007
Table 9: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007
Table 10: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010
Table 11: Major Products, Novartis, Global, Revenue ($m), 2011
Table 12: Planned Filings, Novartis, 2012 to = 2016
Table 13: Major Products, Pharmstandard, Revenue ($m), 2011
Table 14: Major Products, Bayer AG, Global, Revenue ($m), 2011
Table 15: Late-stage Pipeline, Bayer AG, 2011
Table 16: Major Products, Servier, 2011
Table 17: Major Products, Berlin-Chemie/Menarini, 2011
Table 18: Pipeline, Menarini, 2011
Table 19: Medical Device Market ($bn), Russia, 2005–2010
Table 20: Medical Device Market ($bn), Russia, Forecast, 2011–2020
Table 21: Medical Device Market, Russia, Segment Share (%), 2010
Table 22: Diagnostic Imaging Market ($m), Russia, 2005–2010
Table 23: Sales Trends for Major Players-, Diagnostic Devices, Russia, 2005–2010
Table 24: Ophthalmic Devices Market ($m), Russia, 2005–2010
Table 25: Sales Trends for Major Players-, Ophthalmic Devices, Russia, 2010
Table 26: Cardiovascular Devices Market ($m), Russia, 2005–2010
Table 27: Sales Trends for Major Players-, Cardiovascular Devices, Russia, 2010
Table 28: In Vitro Diagnostics Market ($m), Russia, 2005–2010
Table 29: Sales Trends for Major Players-, In Vitro Diagnostics, Russia, 2010
Table 30: Diabetes Care Devices Market ($m), Russia, 2005–2010
Table 31: Sales Trends for Major Players-, Diabetes Care Devices, Russia, 2010
Table 32: Major Medical Device Companies, Russia, Revenue ($m), 2010
Table 33: Major Products, Medtronic, Global, Revenue ($m), 2011
Table 34: Major Products, Siemens, Global, Revenue ($m), 2012
Table 35: Major Products, Philips Healthcare, 2012
Table 36: Reimbursement Drug Lists, Russia, 2011
Table 37: Healthcare Spending, Russia, Patient Share (%), 2005–2010
Table 38: Medical Equipment Classification, Russia, 2011
Table 39: GDP Per Capita ($), Russia, 2005–2010
Table 40: GDP Per Capita ($), Russia, Forecast, 2011–2020
Table 41: GDP, Russia, Annual Growth (%), 2005–2010
Table 42: GDP, Russia, Annual Growth (%), Forecast, 2011–2020
Table 43: GNI Per Capita ($), Russia, 2005–2010
Table 44: Average Consumer Price Index, Russia, 2005–2010
Table 45: Consumer Price, Russia, Annual Change (%), 2005–2010
Table 46: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011–2020
Table 47: Currency Exchange Rate (RUB/$), Russia, 2005–2010
Table 48: Foreign Direct Investment ($bn), Russia, 2005–2010
Table 49: Foreign Exchange Reserves ($bn), Russia, 2005–2010
Table 50: Imports ($bn), Russia, 2005–2010
Table 51: Exports ($bn), Russia, 2005–2010
Table 52: General Government Structural Balance ($bn), Russia, 2005–2010
Table 53: General Government Structural Balance ($bn), Russia, 2011–2020
Table 54: General Government Gross Debt ($bn), Russia, 2005–2010
Table 55: General Government Gross Debt ($bn), Russia, 2011–2020
Table 56: Major Industries, Russia, Production ($bn), 2010
Table 57: Population (m), Russia, 2005–2010
Table 58: Population (m), Russia, Forecast, 2011–2020
Table 59: Urban and Rural Population, Russia, Share (%), 2005–2010
Table 60: Urban and Rural Population, Russia, Share (%), Forecast, 2011–2020
Table 61: Age Groups, Russia, Population Distribution (%), 2005–2010
Table 62: Age Groups, Russia, Population Distribution (%), Forecast, 2011–2020
Table 63: Births (Per 1,000 Population), Russia, 2005–2010
Table 64: Births (Per 1,000 Population), Russia, Forecast, 2011–2020
Table 65: Mortality (Per 1,000 Population), Russia, 2005–2010
Table 66: Mortality (Per 1,000 Population), Russia, Forecast, 2011–2020
Table 67: Major Causes of Mortality (‘000s), Russia, 2008
Table 68: Children <5 Years, Russia, Mortality (Per 1,000 Live Births), 2005–2010
Table 69: Immunization Rate (%), Russia, 2005–2010
Table 70: Major Causes of Male Mortality (‘000s), Russia, 2008
Table 71: Major Causes of Female Mortality (‘000s), Russia, 2008
Table 72: Gender Ratio (M/F), Russia, 2005–2010
Table 73: Life Expectancy at Birth (Years), Russia, 2005–2010
Table 74: Life Expectancy at Birth (Years), Russia, Forecast, 2011–2020
Table 75: Students (‘000s), Russia, 2005–2010
Table 76: Unemployment Rate (%), Russia, 2005–2010
Table 77: Employees, Russia, Segment Share (%), 2008
Table 78: Major Diseases, Russia, Incidence (‘000s), 2008
Table 79: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004
Table 80: Hospitals, Russia, 2005–2010
Table 81: Out-patient Clinics, Russia, 2005–2010
Table 82: Out-patient Clinics, Russia, Urban-Rural, 2005–2010
Table 83: Dental Clinics, Russia, 2005–2010
Table 84: Public Hospitals, Russia, 2005–2010
Table 85: Private Hospitals, Russia, 2005–2010
Table 86: Hospital Beds by Specialization (‘000s), Russia, 2010
Table 87: Beds (Per 1,000 Population), Russia, 2005–2010
Table 88: Physicians (Per 1,000 Population), Russia, 2005–2010
Table 89: Physicians by Specialization (‘000s), Russia, 2010
Table 90: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004
Table 91: Common Air Pollutants (Million Tons), Russia, 2005–2010
Table 92: PM10 (micrograms per cubic meter), Russia, 2005–2010
Table 93: CO2 Emissions (Million Tons), Russia, 2005–2010
Table 94: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005–2010
Table 95: Healthcare Personnel, Russia, Share (%), 2010
Table 96: Healthcare Expenditure (% of GDP), Russia, 2005–2010
Table 97: Healthcare Expenditure (% of GDP), Russia, 2011–2020
Table 98: Healthcare Expenditure, Russia, Share of Major Components (%), 2007
Table 99: Healthcare Expenditure, Russia, Public-Private Share (%), 2005–2010
Table 100: Major Healthcare Trade Fairs, Russia

1.2 List of Figures
Figure 1: Pharmaceutical Market ($bn), Russia, 2005–2010
Figure 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011–2020
Figure 3: Sources of Pharmaceuticals, Russia, Share (%), 2008–2010
Figure 4: Innovative and Generic Products, Russia, Market Share (%), 2007
Figure 5: Distribution Channels, Russia, 2011
Figure 6: Wholesaler Mark-ups (%), Various Countries, 2008
Figure 7: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005–2010
Figure 8: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009
Figure 9: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007
Figure 10: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007
Figure 11: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010
Figure 12: Medical Device Market ($bn), Russia, 2005–2010
Figure 13: Medical Device Market ($bn), Russia, Forecast, 2011–2020
Figure 14: Medical Device Market, Russia, Segment Share (%), 2010
Figure 15: Diagnostic Imaging Market ($m), Russia, 2005–2010
Figure 16: Sales Trends for Major Players-, Diagnostic Devices, Russia, 2005–2010
Figure 17: Ophthalmic Devices Market ($m), Russia, 2005–2010
Figure 18: Sales Trends for Major Players-, Ophthalmic Devices, Russia, 2005–2010
Figure 19: Cardiovascular Devices Market ($m), Russia, 2005–2010
Figure 20: Sales Trends for Major Players-, Cardiovascular Devices, Russia, 2005–2010
Figure 21: In Vitro Diagnostics Market ($m), Russia, 2005–2010
Figure 22: Sales Trends for Major Players-, In Vitro Diagnostics, Russia, 2005–2010
Figure 23: Diabetes Care Devices Market ($m), Russia, 2005–2010
Figure 24: Sales Trends for Major Players-, Diabetes Care Devices, Russia, 2005–2010
Figure 25: Major Medical Device Companies, Russia, Revenue ($m), 2010
Figure 26: Drivers and Barriers, Healthcare Market, Russia, 2012
Figure 27: Organizational Structure of the Healthcare System, Russia, 2011
Figure 28: Health Service Financing, Russia, 2011
Figure 29: Inclusion Process for Reimbursement List, Russia, 2011
Figure 30: Healthcare Spending, Russia, Patient Share (%), 2005–2010
Figure 31: New Drug Approval Process, Russia, 2011
Figure 32: Political System, Russia, 2012
Figure 33: Pharma-2020 Strategy, Russia, 2009
Figure 34: GDP Per Capita ($), Russia, 2005–2010
Figure 35: GDP Per Capita ($), Russia, Forecast, 2011–2020
Figure 36: GDP, Russia, Annual Growth (%), 2005–2010
Figure 37: GDP, Russia, Annual Growth (%), Forecast, 2011–2020
Figure 38: GNI Per Capita ($), Russia, 2005–2010
Figure 39: Average Consumer Price Index, Russia, 2005–2010
Figure 40: Consumer Price, Russia, Annual Change (%), 2005–2010
Figure 41: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011–2020
Figure 42: Currency Exchange Rate (RUB/$), Russia, 2005–2010
Figure 43: Foreign Direct Investment ($bn), Russia, 2005–2010
Figure 44: Foreign Exchange Reserves ($bn), Russia, 2005–2010
Figure 45: Imports ($bn), Russia, 2005–2010
Figure 46: Exports ($bn), Russia, 2005–2010
Figure 47: General Government Structural Balance ($bn), Russia, 2005–2010
Figure 48: General Government Structural Balance ($bn), Russia, 2011–2020
Figure 49: General Government Gross Debt ($bn), Russia, 2005–2010
Figure 50: General Government Gross Debt ($bn), Russia, 2011–2020
Figure 51: Major Industries, Russia, Production ($bn), 2010
Figure 52: Population (m), Russia, 2005–2010
Figure 53: Population (m), Russia, Forecast, 2011–2020
Figure 54: Urban and Rural Population, Russia, Share (%), 2005–2010
Figure 55: Urban and Rural Population, Russia, Share (%), Forecast, 2011–2020
Figure 56: Age Groups, Russia, Population Distribution (%), 2005–2010
Figure 57: Age Groups, Russia, Population Distribution (%), Forecast, 2011–2020
Figure 58: Births (Per 1,000 Population), Russia, 2005–2010
Figure 59: Births (Per 1,000 Population), Russia, Forecast, 2011–2020
Figure 60: Mortality (Per 1,000 Population), Russia, 2005–2010
Figure 61: Mortality (Per 1,000 Population), Russia, Forecast, 2011–2020
Figure 62: Major Causes of Mortality (‘000s), Russia, 2008
Figure 63: Children <5 Years Age, Russia, Mortality (Per 1,000 Live Births), 2005–2010
Figure 64: Immunization Rate (%), Russia, 2005–2010
Figure 65: Major Causes of Male Mortality (‘000s), Russia, 2008
Figure 66: Major Causes of Female Mortality (‘000s), Russia, 2008
Figure 67: Gender Ratio (M/F), Russia, 2005–2010
Figure 68: Life Expectancy at Birth (Years), Russia, 2005–2010
Figure 69: Life Expectancy at Birth (Years), Russia, Forecast, 2011–2020
Figure 70: Students (‘000s), Russia, 2005–2010
Figure 71: Unemployment Rate (%), Russia, 2005–2010
Figure 72: Employees, Russia, Segment Share (%), 2008
Figure 73: Major Diseases, Russia, Incidence (‘000s), 2008
Figure 74: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004
Figure 75: Hospitals, Russia, 2005–2010
Figure 76: Out-patient Clinics, Russia, 2005–2010
Figure 77: Out-patient Clinics, Russia, Urban-Rural, 2005–2010
Figure 78: Dental Clinics, Russia, 2005–2010
Figure 79: Public Hospitals, Russia, 2005–2010
Figure 80: Private Hospitals, Russia, 2005–2010
Figure 81: Hospital Beds by Specialization (‘000s), Russia, 2010
Figure 82: Beds (Per 1,000 Population), Russia, 2005–2010
Figure 83: Physicians (Per 1,000 Population), Russia, 2005–2010
Figure 84: Physicians by Specialization (‘000s), Russia, 2010
Figure 85: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004
Figure 86: Common Air Pollutants (Million Tons), Russia, 2005–2010
Figure 87: PM10 (Microgram Per Cubic Meter), Russia, 2005–2010
Figure 88: CO2 Emissions (Million Tons), Russia, 2005–2010
Figure 89: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005–2010
Figure 90: Healthcare Personnel, Russia, Share (%), 2010
Figure 91: Healthcare Expenditure (% of GDP), Russia, 2005–2010
Figure 92: Healthcare Expenditure (% of GDP), Russia, 2011–2020
Figure 93: Healthcare Expenditure, Russia, Share of Major Components (%), 2007
Figure 94: Healthcare Expenditure, Russia, Public-Private Share (%), 2005–2010
Figure 95: Opportunities and Challenges, Healthcare Market, Russia, 2012

Customers who bought this item also bought

• Russia Generics and Biosimilars
• Drug Delivery Devices Market Outlook in Russian Federation to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• ENT Devices Market Outlook in Russian Federation to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
• Russian Federation Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Nephrology and Urology Devices Market Outlook in Russian Federation to 2017 - Incontinence Devices, Renal Dialysis Equipment and Others
• Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth
• BRIC In-Vitro Diagnostics (IVD) Market in Brazil, Russia, India, China (2010 - 2014)
• Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
• Interventional Neurology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
• Infusion Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018